Healthcare Equipment and Supplies
Company Overview of Bausch & Lomb Incorporated
Bausch & Lomb Incorporated manufactures eye care products. The company offers contact and hydrophobic acrylic intraocular lenses; contact lens care, dry eye, allergy/redness relief, pharmaceutical, and surgical products; and eye vitamins and vision accessories. It also offers contract manufacturing services for sterile and non-sterile solutions, suspensions, ointments, gels, creams, nasals, and injectables. The company was formerly known as Bausch & Lomb Optical Company and changed its name to Bausch & Lomb Incorporated in March 1960. Bausch & Lomb Incorporated was founded in 1853 and is based in Rochester, New York. It has additional offices in Argentina, Australia, Austria, Belgium, Bulgar...
1400 North Goodman Street
Rochester, NY 14609
Founded in 1853
Key Executives for Bausch & Lomb Incorporated
President of Asia-Pacific
Corporate Vice President and President of Latin America Operations
Executive Vice President of Global Business Operations & Process Excellence and Corporate Vice President
Chief Medical Officer and Executive Vice President
Head of Sales for US Vision Care Division
Compensation as of Fiscal Year 2014.
Bausch & Lomb Incorporated Key Developments
Bausch + Lomb Announces Availability of Enhanced BLIS Reusable Injector System for enVista Intraocular Lenses
Mar 26 15
Bausch + Lomb announced the availability of an enhanced BLIS Injector System, which is designed exclusively for use with the enVista, hydrophobic acrylic intraocular lens (IOL). With the new enhancements, eye care practitioners will be provided even greater control, allowing safe delivery of the enVista IOL through unenlarged phaco incisions as small as 2.2 mm. The BLIS injector system was first introduced in February 2014 and features a reusable hand piece made of high-quality, titanium material designed for both reliability and comfort. The proprietary disposable cartridge is designed for easy lens loading and wound entry and smooth delivery of enVista. The enhanced BLIS now includes a softened and tumble-polished plunger tip that is 2mm longer than the previous design, which helps facilitate easier placement in the capsular bag, in addition to several other features to ensure a seamless, positive customer experience.
Vision Source Selects Bausch + Lomb as Vendor for Eye Care Products
Feb 27 15
Bausch + Lomb announced that Vision Source has selected the company as a vendor in the therapeutics category and in contact lenses and lens care products. As part of the relationship, Vision Source will endorse Bausch + Lomb's products together with member pricing discounts and rebate programs. In the therapeutics category, members will be offered the line of Ocuvite and PreserVision eye vitamin and mineral supplements, Soothe eye drops for dry eyes, and Alaway eye drops. For skincare, the ELASTIderm eye product portfolio, which includes eye cream, eye gel and eye serum, will be available to members to help patient's revitalize the skin around their eyes with clinically proven ingredients.
Bausch + Lomb Introduces New Software and Advanced OCT Imaging System for VICTUS(R) Femtosecond Laser Platform
Jan 20 15
Valeant Pharmaceuticals International Inc. announced that its wholly owned subsidiary, Bausch + Lomb, has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for an advanced Swept Source OCT (Optical Coherence Tomography) imaging system and updated software for its VICTUS(R) Femtosecond Laser Platform that will provide surgeons with a new, redesigned interface. The intuitive interface is designed to allow faster, simpler customized treatment planning to help surgeons improve efficiency and patient-flow during surgical procedures. The Swept Source OCT imaging system boasts high resolution imaging of the entire procedure and can be used to drive incision depth and detail the architecture of arcuate incisions. Together, the new software and imaging system will deliver auto-recognition of key landmarks in the eye, including the pupil, anterior capsule and posterior capsule, along with the capsule tilt compensation to maximize lens fragmentation.
Similar Private Companies By Industry
Recent Private Companies Transactions
|No transactions available in the past 12 months.|